PMcardio receives FDA Breakthrough Device Designation — read the full story

PM Magazine

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

Editor's Choice

Winners+of+AHA's+Health+Tech+Competition+2024

Powerful Medical Wins Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Timothy D. Henry, MD joins Powerful Medical's US Scientific board

Timothy D. Henry, MD Joins Powerful Medical’s US Scientific Advisory Board Amidst Entry to the US Market

Jolimont Hospital Helora

Jolimont Hospital in Belgium Implements PMcardio AI to Detect Acute Myocardial Infarction

ECG Interpretation Tools Compared – Why PMcardio Stands Out

Interpreting ECGs accurately and swiftly is essential for clinicians at every frontline patient encounter—from primary care to emergency settings. Choosing the appropriate interpretation tool significantly impacts patient outcomes. Today, we explore three accessible solutions for clinicians: Conventional ECG Algorithms, General AI language models like ChatGPT, and PMcardio.

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.
ACC_2025

Powerful Medical at ACC 2025: Advancing AI in Cardiovascular Care

We are excited to announce that Powerful Medical will be attending the American College of Cardiology (ACC) 2025 Conference, taking place from March 29th – 31st, 2025, in Chicago, IL, USA. Once again, we have a strong presence at the conference, with multiple papers being presented, underscoring our continued leadership in AI-driven cardiovascular diagnostics.

Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update

Our new major update includes a dashboard and insights, real-time outcome feedback, enhanced digitization, and faster explainability. With AI-powered ECG interpretation and advanced analytics, healthcare institutions gain actionable data to optimize clinical workflows, improve patient outcomes, and drive efficiency.

Stay on the pulse with our newsletter

Your submission was successful